Leadership Team

Chris Chan, Pharm D., is the Chief Executive Officer of OptivanceX. He is also the co-founder of Gojji, Inc, a pharmacist-led chronic disease management company. Chris has more than 17 years of experiences in pharmacy benefit management. Previously, he was the Chief Pharmacist at a Medicaid and Medicare Plan. He has received numerous awards, including the Pharmacy Benefit Management Institute (PBMI) Excellence Award for its Innovative Community Pharmacy P4P program. Chris is passionate about improving quality of care, promote medication optimization & safety, and clinical outcomes through innovative benefit and program design.

He holds a bachelor’s degrees in chemistry and Biology from the University of California, Irvine, a Doctor of Pharmacy Degree from the University of Southern California. 

Dmitry Zalesov is the Chief Technology Officer at OptivanceX. Dmitry brings a profound passion for data and a remarkable ability to uncover correlations and dependencies as Chief Technology Officer of OptivanceX. Previously he served as Global Head of Data Intelligence at SoftwareOne. 

Dawit has a strong Scientific and Engineering background and extensive work experience for Pharmacy Service, Medical Equipment and Filtration companies. 

Mason is a 7-year NBA veteran and former Academic All American at Duke University. He is an active angel investor and serves as an advisor to healthcare startups as well as life-sciences accelerator: The Prysm Institute. 

Priscilla is currently the Group Executive Marketing and Corporate Affairs of Commonwealth Bank of Australia and CEO of Emerge.me. Prior to this, Priscilla was Senior Vice President and Chief Marketing Officer at AXA Financial in the US, where she had responsibility for transforming the end-to-end customer experience, as well as leading global digital marketing initiatives. 

She has also held executive leadership roles at AmeriHealth Caritas, Sun Life Financial US, and Lincoln National Corporation, with responsibility for leading business units, stakeholder engagement, marketing, corporate affairs, investor relations and business development functions.

Dr. Sherief Shaaban, Pharm D., serves as the Vice President of Strategic Ventures for Catalent Pharma Solutions – the world leader in advanced drug delivery technologies and development services for pharmaceutical, biotechnology, and consumer health companies with revenues of $2.7 billion.  

Prior to this he served as Vice President, Market Access National Accounts at Novo Nordisk where he led the managed care and trade account teams responsible for establishing strategic partnerships with the largest health plans and PBMs representing over 85% of Novo Nordisk US revenue.  

Dr. Shaaban also led the B2B Managed Markets team at Eli Lilly & Company for the Eastern Region with responsibility for managed care organizations, Medicare Part D plans, Medicaid departments, and managed Medicaid plans, which in total represented significant revenues for Lilly.